台股 » 個股 » 中化生 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

中化生

(1762)
可現股當沖
  • 股價
    47.30
  • 漲跌
    ▲1.10
  • 漲幅
    +2.38%
  • 成交量
    247
  • 產業
    上市 生技醫療類股
  • 250人加入追蹤

    立即追蹤

  • 本地時間:14:30

     
中化生 (1762)籌碼相關-富邦-永康 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

富邦-永康 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2024/05/10047.0500.0047.3002850.01%
2024/05/02046.4500.0046.3002880.01%
2024/04/2500.00145.0544.90-1293-0.34%
2024/04/22144.8000.0044.9513080.32%
2024/04/150.146.8000.0046.150.13200.03%
2024/04/110.147.9000.0047.650.13090.02%
2024/04/080.148.0000.0048.200.13010.02%
2024/03/2700.00249.5049.70-2283-0.70%
2024/03/2500.00149.8549.90-1281-0.36%
2024/03/20150.0000.0050.2012840.35%
2024/03/19149.3000.0049.2512800.36%
2024/03/0400.00149.5049.60-1329-0.30%
2024/02/16150.4000.0050.5014380.23%
2024/02/151.249.5900.0049.851.24390.26%
2024/02/050.250.8000.0050.500.24370.03%
2024/02/020.151.5000.0051.100.14350.01%
2024/02/010.151.7000.0051.500.14350.01%
2024/01/190.151.6000.0051.200.14490.02%
2024/01/17152.1000.0051.4014440.23%
2024/01/150.153.9000.0053.800.14360.02%
2023/12/2500.00856.2556.20-8461-1.73%
2023/12/19457.0000.0057.0044690.85%
2023/12/1800.00058.0057.4004750.00%
2023/12/1500.00256.7556.70-2472-0.42%
2023/12/140.156.4000.0056.200.14860.02%
2023/12/1200.00156.6056.60-1490-0.20%
2023/12/1100.00457.7057.10-4490-0.81%
2023/12/08258.1500.0058.1024870.41%
2023/12/060.159.3000.0058.600.14950.02%
2023/12/0400.00060.4060.3004870.00%
2023/12/0100.00159.5059.30-1475-0.21%
2023/11/300.159.2000.0058.500.14660.02%
2023/11/291.159.0100.0059.001.14670.24%
2023/11/285.158.96259.4059.203.14660.66%
2023/11/27362.07361.4761.3004380.00%
2023/11/24357.9700.0057.9033840.78%
2023/11/2200.00157.2057.20-1379-0.26%
2023/11/20257.45157.6057.6013770.26%
2023/11/1600.00255.6556.00-2371-0.54%
2023/11/15155.4000.0055.4013770.26%
2023/11/13155.7000.0055.3013910.26%
2023/11/0900.00255.1054.70-2397-0.50%
2023/09/22459.0000.0059.0041,0370.39%
2023/09/1500.00361.4061.80-31,204-0.25%
2023/09/1400.00461.6561.60-41,210-0.33%
2023/09/1300.00160.9061.20-11,215-0.08%
2023/09/11861.9300.0060.5081,2360.65%
2023/09/0800.00060.8060.2001,2460.00%
2023/07/2600.00077.5076.1002,5350.00%
2023/07/24177.1000.0077.0012,6470.04%
2023/07/19080.0000.0079.3002,6960.00%
2023/07/18279.3000.0078.0022,7490.07%
2023/07/17180.0000.0080.3012,7810.04%
2023/07/1400.00780.3380.30-72,815-0.25%
2023/07/13379.0000.0078.5032,8580.10%
2023/07/12378.00180.0078.4022,9360.07%
2023/07/111181.32183.8081.30102,9780.34%
2023/06/3000.00293.5592.40-23,197-0.06%
2023/06/2800.00191.5091.80-13,426-0.03%
2023/06/27290.20288.6089.3003,4260.00%
2023/06/1600.00187.1086.60-13,523-0.03%
2023/06/12284.9500.0084.0023,7070.05%
2023/06/09392.00192.7092.8023,8770.05%
2023/06/08188.9000.0087.7013,9550.03%
2023/06/0700.00089.8089.5003,9570.00%
2023/06/06190.20290.3590.40-13,975-0.03%
2023/06/05188.9000.0089.4014,0840.02%
2023/06/0200.00388.2087.60-34,115-0.07%
2023/06/01389.7900.0089.1034,1530.07%
2023/05/2900.00192.2091.80-14,227-0.02%
2023/05/26191.1000.0090.7014,2230.02%
2023/05/24594.12193.8094.3044,2400.09%
2023/05/19193.50193.0092.5004,1840.00%
2023/05/18498.03398.0097.8014,1150.02%
2023/05/17598.66599.4898.5004,1000.00%
2023/05/16296.45396.7096.60-14,034-0.02%
2023/05/12293.7000.0093.8024,0280.05%
2023/05/11293.7000.0094.9023,9510.05%
2023/05/103100.204102.50102.50-13,756-0.03%
2023/05/09193.3000.0093.2013,6390.03%
2023/05/08195.20597.5695.90-43,622-0.11%
2023/05/05399.6000.0098.6033,5810.08%
2023/05/0300.00195.4095.70-13,447-0.03%
2023/04/28293.90395.9795.60-13,399-0.03%
2023/04/27092.60092.7091.8003,3190.00%
2023/04/24188.8000.0089.2013,2280.03%
2023/04/21187.90188.5087.4003,2280.00%
2023/04/2000.00292.1590.20-23,164-0.06%
2023/04/19293.55193.6093.9013,1240.03%
2023/04/1800.00893.0094.40-83,086-0.26%
2023/04/171493.76993.5293.1053,0380.16%
2023/04/14291.0000.0091.5022,9550.07%
2023/04/13089.1000.0088.0002,8700.00%
2023/04/11279.65479.5381.80-22,768-0.07%
中化生魚油原料藥產能倍增最快年底過美認證 明年營收再登高Anue鉅亨-2022/11/14
年度傑出生技產業獎 中化生、藥華藥入列Anue鉅亨-2022/07/22
〈中國限電〉中印限電危機原料藥再度供給失衡 中化生、台耀迎轉單潮Anue鉅亨-2021/10/07
中化生 相關文章